Vikas Lifecare Limited

As of March 31, 2026, Vikas Lifecare Limited carries a market capitalization of 1.97B, placing it among publicly traded companies globally. Its enterprise value stands at 2.41B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Vikas Lifecare Limited has 1.86B shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.35, and the price-to-book ratio stands at 0.36.

These figures are as of March 31, 2026. The EV/Sales ratio of 0.45 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.41B versus a market cap of 1.97B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Vikas Lifecare Limited maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.14, indicating elevated leverage, while an interest coverage ratio of -7.97 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2026. The company generates approximately 149.32M in revenue per employee across its workforce of 36.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, Vikas Lifecare Limited recorded an income tax benefit of -97.84M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -939.23M and -842.34M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Vikas Lifecare Limited's stock has declined approximately 46.01% over the past 52 weeks. The 50-day moving average sits at 1.23, while the 200-day moving average is 1.43.

Over the twelve months ended March 31, 2026, Vikas Lifecare Limited generated 5.38B in revenue and converted that into -842.34M in net income, yielding earnings per share of -0.47. EBITDA reached -478.37M, while operating income came in at -590.05M.

As of March 31, 2026, Vikas Lifecare Limited holds 610.70M in cash and equivalents against 1.05B in total debt, resulting in a net debt position of 1.04B. Total book value stands at 5.51B, with working capital of 1.02B providing operational flexibility.

Over the twelve months ended March 31, 2026, Vikas Lifecare Limited posted a gross margin of 3.00, reflecting its pricing power and cost economics. The operating margin of -10.98 and net profit margin of -15.67 provide insight into operational efficiency.

Vikas Lifecare Limited's most recent stock split took place on October 29, 2021 with a 71:74 split ratio.